# Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis

> **NCT00004494** · PHASE1 · COMPLETED · sponsor: **Stony Brook University** · enrollment: 18 (estimated)

## Conditions studied

- Sepsis
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Adult

## Interventions

- **DRUG:** vasoactive intestinal peptide

## Key facts

- **NCT ID:** NCT00004494
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2022-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004494, "Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00004494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*